Intra-arterial versus standard intravenous administration of lutetium-177-DOTA-octreotate in patients with NET liver metastases: study protocol for a multicenter, randomized contro... von Ebbers, Sander C., Braat, Arthur J. A. T., Moelker, Adriaan, Stokkel, Marcel P. M., Lam, Marnix G. E. H., Barentsz, Maarten W.

Volltext

Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide th... von Ebbers, Sander C., Brabander, Tessa, Tesselaar, Margot E. T., Hofland, Johannes, Braat, Manon N. G. J. A., Wessels, Frank J., Barentsz, Maarten W., Lam, Marnix G. E. H., Braat, Arthur J. A. T.

Volltext

Baseline Imaging Derived Predictive Factors of Response Following [ 177 Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Bas... von van der Sar, Esmée C A, Kühr, Adinda J S, Ebbers, Sander C, Henderson, Andrew M, de Keizer, Bart, Lam, Marnix G E H, Braat, Arthur J A T

Volltext

Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature von Braat, Manon N G J A, Ebbers, Sander C, Alsultan, Ahmed A, Neek, Atal O, Bruijnen, Rutger C G, Smits, Maarten L J, de Bruijne, Joep, Lam, Marnix G E H, Braat, Arthur J A T

Volltext

Gallium-68-somatostatin receptor PET/CT parameters as potential prognosticators for clinical time to progression after peptide receptor radionuclide therapy: a cohort study von Ebbers, Sander C., Heimgartner, Muriël, Barentsz, Maarten W., van Leeuwaarde, Rachel S., van Treijen, Mark J. C., Lam, Marnix M. E. G., Braat, Arthur J. A. T.

Volltext

Dose–response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastases von Ebbers, Sander C., van Roekel, Caren, Braat, Manon N. G. J. A., Barentsz, Maarten W., Lam, Marnix G. E. H., Braat, Arthur J. A. T.

Volltext

A Rapid and Safe Infusion Protocol for 177 Lu Peptide Receptor Radionuclide Therapy von Ebbers, Sander C., Barentsz, Maarten W., de Keizer, Bart, Krijger, Gerard C., Lam, Marnix G.E.H., Braat, Arthur J.A.T.

Volltext

A Rapid and Safe Infusion Protocol for Lu-177 Peptide Receptor Radionuclide Therapy von Ebbers, Sander C., Barentsz, Maarten W., de Keizer, Bart, Krijger, Gerard C., Lam, Marnix G. E. H., Braat, Arthur J. A. T.

Volltext

A Rapid and Safe Infusion Protocol for 177Lu Peptide Receptor Radionuclide Therapy von Ebbers, Sander C, Barentsz, Maarten W, de Keizer, Bart, Krijger, Gerard C, Lam, Marnix G E H, Braat, Arthur J A T

Volltext

Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide th... von Ebbers, Sander C, Brabander, Tessa, Tesselaar, Margot E.T, Hofland, Johannes, Braat, Manon N.G.J.A, Wessels, Frank J, Barentsz, Maarten W, Lam, Marnix G.E.H, Braat, Arthur J.A.T

Volltext

Intra-arterial versus standard intravenous administration of lutetium-177-DOTA-octreotate in patients with NET liver metastases: study protocol for a multicenter, randomized contro... von Ebbers, Sander C, Braat, Arthur J A T, Moelker, Adriaan, Stokkel, Marcel P M, Lam, Marnix G E H, Barentsz, Maarten W

Volltext

Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature von Braat, Manon N G J A, Ebbers, Sander C, Alsultan, Ahmed A, Neek, Atal O, Bruijnen, Rutger C G, Smits, Maarten L J, de Bruijne, Joep, Lam, Marnix G E H, Braat, Arthur J A T

Volltext

Baseline Imaging Derived Predictive Factors of Response Following [Lu-177]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Base... von van der Sar, Esmée C.A, Kühr, Adinda J.S, Ebbers, Sander C, Henderson, Andrew M, Keizer, Bart de, Lam, Marnix G.E.H, Braat, Arthur J.A.T

Volltext

Gallium-68-somatostatin receptor PET/CT parameters as potential prognosticators for clinical time to progression after peptide receptor radionuclide therapy: a cohort study von Ebbers, Sander C, Heimgartner, Muriel, Barentsz, Maarten W, van Leeuwaarde, Rachel S, van Treijen, Mark J. C, Lam, Marnix M. E. G, Braat, Arthur J. A. T

Volltext